BMRC ethically permits human trials of Bharat Biotech's vaccine in Bangladesh
Covaxin, the Covid-19 vaccine made by India's Bharat Biotech, got ethical permission to conduct human trial in Bangladesh.
Bangladesh Medical and Research Council (BMRC) has given the permission on July 18, the council's Chairman Syed Modasser Ali told The Daily Star.
He said International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), the CRO of the vaccine, sought permission for clinical trial few months ago and the ethical permission for holding the clinical trial was given as all the requirements were fulfilled.
Although BMRC gave ethical permission to bring the vaccine in the country, the CRO (contract research organisation) has to take permission from Directorate General of Drug Administration, he further said.